References
- Samuelsson M, Jokinen J, Nordström A-L, Nordström P. CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatr Scand 2006; 113: 44–7
- Sher L, Mann JJ. Neurobiology of suicide. Textbook of medical psychiatry, JC Soares, S Gershon. Marcel Dekker, New York 2003; 701–711
- Geracioti TDJr, Keck PEJr, Ekhator NN, West SA, Baker DG, Hill KK, et al. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid. Biol Psychiatry 1998; 44: 228–33
- Sher L, Oquendo MA, Li S, Huang Y, Grunebaum MF, Burke AK, et al. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism. Neuropsychopharmacology 2003; 28: 1712–19
- Traskman L, Asberg M, Bertilsson L, Sjostrand L. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 1981; 38: 631–6
- Engström G, Alling C, Blennow K, Regnell G, Traskman-Bendz L. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsychopharmacol 1999; 9: 399–405
- Roy A, Agren H, Pickar D, Linnoila M, Doran AR, Cutler NR, et al. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: Relationship to suicidal behavior and dexamethasone nonsuppression. Am J Psychiatry 1986; 143: 1539–45
- Jones JS, Stanley B, Mann JJ, Frances AJ, Guido JR, Traskman-Bendz L, et al. CSF 5-HIAA and HVA concentrations in elderly depressed patients who attempted suicide. Am J Psychiatry 1990; 147: 1225–7
- Roy A, De Jong J, Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry 1989; 46: 609–12
- Traskman-Bendz L, Alling C, Alsen M, Regnell G, Simonsson P, Ohman R. The role of monoamines in suicidal behavior. Acta Psychiatr Scand 1993; 371 Suppl: 45–7
- Montgomery SA, Montgomery D. Pharmacological prevention of suicidal behaviour. J Affect Disord 1982; 4: 291–8
- Agren H. Life at risk: Markers of suicidality in depression. Psychiatr Dev 1983; 1: 87–103
- Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, et al A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord, in press.
- Sher L, Mann JJ, Traskman-Bendz L, Huang Y, Fertuck EA, Stanley BH. Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters. J Affect Disord 2006; 90: 83–9